Michela Sgarzi
Bologna, 40138, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Beyond EGFR inhibition in head and neck squamous cell carcinoma: Overcoming resistance mechanisms and novel therapeutic frontiers.
Journal: Critical reviews in oncology/hematology
Published: December 07, 2025
IL-1-mediated inflammation promotes metastatic dissemination and resistance to EGFR-targeted therapy.
Journal: NPJ precision oncology
Published: October 31, 2025
Nuclear Mechanotransduction at the Crossroads: How Membrane Receptors Remodel the Perinuclear Cytoskeleton to Drive Cancer and Disease.
Journal: International journal of biological sciences
Published: October 30, 2025
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation.
Journal: Communications biology
Published: December 17, 2022
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy.
Journal: Frontiers in cell and developmental biology
Published: October 29, 2022
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies.
Journal: Frontiers in oncology
Published: December 08, 2021
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization.
Journal: Cellular & molecular biology letters
Published: October 21, 2021
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 21, 2021
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies.
Journal: International journal of molecular sciences
Published: July 11, 2020
Last Updated: 09/26/2026